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Abstract
Crystallographic analysis of macromolecules depends on large, well-ordered crystals, which often 
require significant effort to obtain. Even sizable crystals sometimes suffer from pathologies that 
render them inappropriate for high-resolution structure determination. Here we show that 
fragmentation of large, imperfect crystals can provide a simple path for high-resolution structure 
determination by serial femtosecond crystallography or the cryoEM method MicroED.
Introduction
Large and perfect crystals are desirable for structure determination because they yield a 
strong signal over background. In reality, crystals of biological material are not perfect. In 
the mosaic model, a real, imperfect crystal is composed of several small but well-ordered 
blocks1. These mosaic blocks have a finite size, are misaligned with respect to each other, 
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and may be composed of unit cells with different dimensions2. Depending on the nature and 
degree of disorder between the mosaic blocks, an imperfect crystal may exhibit a plethora of 
pathologies, which may hamper subsequent data reduction, limit the resolution of the final 
model, and can prevent structure determination altogether (Supplementary figures 1–9). 
Many such defects primarily affect larger crystals, and small crystals may yield superior data 
quality where diffraction is not limited by the number of diffracting unit cells in the crystal3.
For these reasons, methods such as serial femtosecond crystallography (SFX)4 at an X-ray 
free-electron laser (XFEL) and the electron cryomicroscopy (cryoEM) method 
microelectron diffraction (MicroED)5 are actively being developed. These methods can yield 
structures to resolutions better than 1 Å from crystals that are significantly smaller than 
those which are required for standard crystallography: ~10,000× smaller in volume for 
XFEL and ~1,000,000× smaller for MicroED. In fact, in both these techniques large crystals 
can prove problematic. This is because large crystals can clog up the nozzle of certain SFX 
sample delivery systems6,7, while in MicroED the large electron scattering cross-section 
implies that absorption extinguishes diffraction when the sample is too thick8.
Here we show that sonication, vigorous pipetting, or vortexing can be used to break large 
imperfect crystals into small, single-crystal fragments that are suitable for data collection 
and atomic structure determination (Figure 2). Delicate samples may benefit from gentler 
fragmentation by vortexing, while harsher methods such as pipetting and ultimately 
sonication are required to break more robust crystals. In many cases, the untreated crystals 
were mosaic, yielded diffraction patterns with multiple lattices, or were otherwise not 
suitable for standard crystallographic experiments (Figure 2, Supplementary figures 1–9). In 
the case of the amyloid-forming peptide of tau (VQIVYK), what appeared to be large 
crystals were in fact crystal bundles that produced low resolution powder-like diffraction. 
These problems are traditionally overcome by modifying the crystallization conditions to 
optimize crystal growth and quality a process that can be tedious and labor intensive, 
particularly when crystal pathologies do not become apparent until data processing. 
Breaking of large crystals by physical means produced fragments that appeared 
crystallographically homogeneous and yielded diffraction data at atomic resolution, void of 
the above artifacts. This was true even without further optimization of the growth conditions 
for crystals formed by various macromolecules of molecular weights between 0.7 kDa and 
34.6 kDa, and solvent contents ranging from 30% to 60% with a range of unit cell 
dimensions and space groups (Table 1). MicroED has already allowed rapid structure 
solution from several peptide fragments that resisted solution using microfocus synchrotron 
sources in spite of many months of crystal optimization (Supplementary figures 2–4), and 
the approach could be used for samples where large crystals exist but standard 
crystallographic methods fail, owing to crystal imperfections.
Fragmentation was tested on eight proteins: lysozyme, TGF-βm:TβRII, xylanase, thaumatin, 
trypsin, proteinase K, thermolysin, and a segment of the protein tau (Figure 2, left column). 
These proteins readily form crystals that are large—too big for MicroED and SFX 
experiments using liquid injectors—but without crystal growth optimization sometimes 
exhibit pathologies. These large crystals were broken apart by mechanical means prior to 
preparation on cryoEM grids. Micro- or nanometer-sized crystal fragments appeared evenly 
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distributed on the grid, and even when grids were densely populated single-crystal data sets 
could be collected by using the selective area aperture.
MicroED is inherently well suited to study crystal fragments. Electrons interact strongly 
with matter so that large crystals are not required to detect high-resolution Bragg 
reflections8. MicroED has been used to determine the structures of the enzymes 
lysozyme5,9, proteinase K10, catalase11,12, and Ca2+-ATPase12. It was also recently used to 
solve the 1.4 Å resolution structure of the toxic NAC-core of α-synuclein, where diffraction 
data were collected from crystals smaller than the wavelength of visible light13. We 
previously demonstrated that crystals thinner than ~400 nm are suitable for MicroED and 
routinely yield atomic resolution information. The highest resolution structures reported so 
far by using MicroED are from four prion protein fragments determined at 1 Å resolution 
solved by direct phasing methods14.
For each sample, data were collected from 2–10 crystal fragments, and data sets merged for 
completeness and multiplicity (Table 1). Although we have previously published two 
structures where a single nanocrystal was sufficient for structure determination9,11 multi-
crystal merging is generally preferred. This is partly because the grid on which the crystals 
are mounted limits the accessible rotation range during data collection, and partly because 
small, weakly scattering samples require a more intense beam to yield statistically accurate 
measurements of the Bragg reflections, and may be irreversibly damaged before a complete 
data set can be obtained. Recording narrow wedges with fewer exposures for each crystal 
involves a tradeoff between limiting the damage to the sample and maintaining a sufficient 
dose rate for the signal from high-resolution reflections to be accurately integrated. Because 
the resolutions obtained by MicroED are comparable or better to what was obtained by X-
ray diffraction before sonication, it appears that fragmentation only broke apart the large 
crystals into small crystal domains but did not otherwise damage the lattice order.
The macromolecular structures in this study were phased using molecular replacement (MR) 
or by direct methods and refined using electron scattering factors15. In all cases, the refined 
model fits the calculated density well (Figure 2, middle column) with an overall real-space 
map correlation coefficient ranging from 0.72 to 0.91 (RSCC; Table 1). The resulting 
simulated-annealing (SA) composite-omit maps (Figure 2, right column) match their 
respective models very well, indicating that the data are indeed high quality and unbiased. 
Further, the SA omit maps for lysozyme reveal depressions or holes in the aromatic rings of 
amino acid side chains, while for proteinase K toroidal densities were observed even for 
proline residues at the 1.6 Å resolution cutoff. A well-coordinated calcium ion is clearly 
visible in the omit map for trypsin, as is one of the iodides in the xylanase structure. 
Individual atoms are visible in the density for the tau peptide, and several residues show 
positive 2mFo-DFc peaks for hydrogen atoms; for one residue, modeled hydrogens allowed 
us to unambiguously place the correct sidechain rotamer.
All structures were determined between 1.1–2.9 Å resolution. We note that the R-factors 
from model refinement are generally higher in MicroED than typical values obtained in X-
ray crystallography at similar resolutions. Others and we have already made such 
observations in previously published studies5,9,12. We believe that the main reason is lack of 
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adequate electron scattering factors in the crystallographic refinement software. X-rays are 
scattered by the electron cloud of an atom while electrons are scattered by the atomic 
Coulomb potential, which arises from the nucleus as well as its surrounding electrons. 
Current electron scattering factor tables do not adequately account for this difference and 
this may contribute to the residual between observed and calculated structure factor 
amplitudes leading to higher than normal crystallographic and free R-factors. We note that 
the gap between Rwork and Rfree is small indicating no concerns of overfitting 
(Supplementary figure 10).
Discussion
Breaking large crystals into well-formed crystal fragments has a long history in 
crystallography; indeed X-ray diffraction was discovered from broken up pieces of a copper 
sulfate crystal16. Sonication17 and vortexing18 have previously been used to prepare crystals 
of suitable size for XFEL measurements. By breaking up one imperfect large crystal into 
thousands or even millions of smaller crystallites and recombining a well-diffracting subset 
during data processing, we have used MicroED to determine the structure of eight different 
proteins to high resolution. Fragmentation does not increase the effort required for sample 
screening, and future work on automation is expected to reduce the time for data collection 
irrespective of how the sample was prepared. Importantly, as demonstrated by the breadth of 
size and packing of macromolecules whose crystals we investigated, this is a broadly 
applicable approach where large crystals are available. Fragmentation widens the scope of 
diffraction methods such as MicroED and SFX to include samples that do not exclusively 
form tiny crystals but instead form large, imperfect crystals.
Online methods
Large crystals (>500 µm along the longest edge) were grown via hanging-drop vapor 
diffusion at room temperature using previously established protocols. All enzymes were 
purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise noted.
• Tau peptide (VQIVYK) was dissolved in distilled water and crystals prepared by 
mixing tau peptide with arachidonic acid and meclocycline sulfosalicylate. 
Crystals formed with a 1:2 drop peptide to precipitant ratio from 65–70% 
ethylene glycol in Tris pH 8.5.
• Lysozyme (G. gallus) crystals were prepared by equilibrating equal volumes of 
50 mg/ml lysozyme in water and 1.7 M sodium chloride, 50 mM sodium acetate 
pH 4.7.
• TGF-βm:TβRII was expressed and purified as described before20,21. Crystals 
were grown from 0.5 µl of protein (20 mg/ml), 0.25 µl mother liquor, and 0.2 µl 
seed stock in 100 mM HEPES/NaOH pH 7.5 and 45% MPD.
• Xylanase from T. reesei (Hampton Research, Aliso Viejo, CA) was dialyzed 
against 10 mM bicine pH 9.0, 1 mM magnesium sulfate, 1 mM DTT and 
combined with a precipitant solution containing 0.3 M sodium iodide, 1.2–1.3 M 
ammonium sulfate, and 100 mM bicine pH 9.022.
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• Thaumatin (T. daniellii) crystals were grown from 2 µL of protein (25 mg/ml in 
water) and Hampton Research Index Reagent 26 (1.1 M ammonium tartate pH 
7.0).
• Trypsin (B. taurus) was dissolved (60 mg/ml) in 10 mg/ml benzamidine, 3 mM 
calcium chloride and equilibrated against 4% (w/v) PEG4000, 0.2 M lithium 
sulfate, 0.1 M MES pH 6.5 and 15% ethylene glycol.
• Proteinase K (E. album) crystals were grown by combining 2 µL of protein 
solution (50 mg/ml) with 2 µL of precipitant solution (1.0–1.3 M ammonium 
sulfate, 0.1 M Tris pH 8.0)10.
• Thermolysin from B. thermoproteolyticus (Hampton Research, Aliso Viejo, CA) 
crystals were prepared by equilibrating a 160 mg/ml solution of thermolysin 
(45% dimethyl sulfoxide, 50 mM Tris pH 7.5 and 2.5 M cesium chloride) over 
0.5 ml of water23.
Drops containing the crystals were placed in separate microfuge tubes and suspended in 
crystal mother liquor. A sonicating water bath with electronic control (Elmasonic P30H, 
Singen, Germany) was set at its lowest power (30% at 37 kHz) for gentle agitation of the 
crystals in the tube. With the tube sealed, its tip was briefly submerged in the activated water 
bath for 0.5 s. Alternatively; crystals were fragmented by vigorously pipetting a crystal 
suspension in mother liquor (trypsin and thaumatin) or vortexed with 0.5 mm disruption 
glass beads in a 1.5 ml reaction tube for 2 s (TGF-βm:TβRII). A detailed protocol for crystal 
fragmentation was published online24.
The solution containing fragmented crystals was then applied to transmission electron 
microscope (TEM) grids with carbon film support, and plunge-frozen in liquid ethane. 
Frozen grids were mounted in a Gatan Model 626 cryo-specimen holder and examined using 
an FEI Tecnai F20 field-emission TEM operated at an accelerating voltage of 200 kV, which 
corresponds to a de Broglie wavelength of 0.025 Å, and screened for crystals in over-
focused diffraction mode. Where a single still shot revealed strong diffraction, data were 
collected as continuous rotation tilt series9. Individual frames were recorded on a TVIPS 
TemCam-F416 as 4 s exposures while the stage was rotating at 0.09°/s, except for tau 
peptide, which was rotated at 0.29°/s during 2 s exposures. For the macromolecular samples, 
the absolute tilt angle was generally <35° (<65° for tau peptide). Data sets collected from 
each crystal spanned between 30° and 135°, corresponding to a total dose no greater than 
1.2–5.5 e−/Å2 at the given rotation rate. The selective area aperture of the TEM was used to 
limit the area from which data were collected, making it possible to select a single crystal 
fragment. The virtual detector distance varied between 730 mm and 3.6 m for the different 
data sets, corresponding to a maximum resolution between 0.95 Å and 2.0 Å in the detector 
corners at an acceleration voltage of 200 kV. The movie frames recorded in rolling shutter 
mode on the TVIPS TemCam-F416 CMOS camera were converted to SMV format, while 
preserving as much as possible of the metadata necessary for subsequent processing25. 
Detailed protocols for data collection were published recently26.
Sweeps were corrected to account for negative pixel values10, then indexed and integrated in 
MOSFLM27 using its graphical interface iMOSFLM28, or in XDS29. To further probe the 
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scattering power of the crystallites, diffraction patterns were initially processed without 
imposing any resolution cutoffs other than those entailed by the geometry of the experiment. 
Except for the tau peptide and TGF-βm:TβRII, the high-resolution limits due to factors 
other than the area of the detector were instead determined case-by-case to give stable 
processing during refinement of the atomic model. Multi-crystal scaling and merging was 
performed in AIMLESS30. Structures were phased by molecular replacement using 
MOLREP31 from the PDB entries 3j6k, 1ktz, 2dfb, 4ek0, 2ptn, 5i9s, and 2tli for lysozyme, 
TGF-βm:TβRII, xylanase, thaumatin, trypsin, proteinase K, and thermolysin, respectively, 
or by direct methods using SHELXT32. A free R set comprising approximately 5% of the 
unique reflections was copied from the deposited data for each search model. The deposited 
data for the xylanase and trypsin models do not define a free set; instead a new set was 
chosen using freerflag33.
Maximum likelihood structure refinement was carried out in phenix.refine34 using electron 
scattering factors15. Explicit water molecules were automatically modeled by phenix.refine 
and subsequently manually curated in Coot35. SA composite omit maps were computed 
from the refined models using CNS36 with electron scattering factors37. For these 
calculations, charged species were manually removed from the phasing models, because 
they are not included in CNS’s electron scattering library. The SA protocol was defined to 
exclude ~5% of the structure at a starting temperature of 2500 K. Protocols for data analysis 
in MicroED were recently published25.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Crystals before and after fragmentation and their X-ray and MicroED diffraction 
patterns
(a) Top row: light micrographs of imperfect crystals before fragmentation. Scale bars are 
500 µm, except for tau peptide and TGF-βm:TβRII where the scale bar is 50 µm. Bottom 
row: electron micrographs of fragmented crystals (scale bars are 5 µm). The X-ray 
diffraction patterns exhibit multiple lattices (b; thaumatin) or even powder-like diffraction 
(d; trypsin). These pathologies are not present in crystallite fragments investigated by 
MicroED (c, e). The inset shows a close-up of the spot indicated by the blue circle. X-ray 
diffraction patterns were collected on a Cu-Kα home over a 0.37° rotation range; MicroED 
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patterns were recorded as detailed in the methods section. Further examples are shown in 
Supplementary figures 1–9.
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Figure 2. Eight atomic resolution structures determined by MicroED from crystal fragments
Left column: ribbon representations of the corresponding macromolecules. The tau peptide 
model indicates a β-sheet generated by crystal packing. Middle column: 2mFo-DFc charge 
density maps contoured at 1.5 σ above the mean, showing eight residues in loop regions of 
the respective structures, where m is the figure of merit and D is derived from coordinate 
error estimates. For TGF-βm:TβRII one of the disulfide bonds is shown. Right column: SA 
composite omit maps contoured at 1 σ above the mean, except for the maps from lysozyme 
and proteinase K, which are contoured at 1.5 σ above the mean. Depressions or holes can be 
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observed in the density of side chains of aromatic residues for tau peptide and lysozyme, and 
for proline residues in the proteinase K structure. Iodide and calcium ions are visible in the 
omit maps for xylanase and trypsin, respectively. All figures were generated using PyMol19.
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